Bactolife, a Copenhagen, Denmark-based gut microbiome health company, raised USD5m in funding.
The Bill & Melinda Gates Foundation committed the amount.
The company intends to use the funds to accelerate the impact of its technology platform to develop Binding Proteins, a novel biologic solution to reduce the risk of gut infections in humans and animals.
Led by Mads Laustsen, CEO, and Sebastian Søderberg, Deputy CEO, Bactolife is a company committed to advancing gut microbiome health in the food and feed industry. Bactolife uses its proprietary Binding Protein technology to develop novel biological solutions, strengthening the gut microbiome and helping solve the daunting challenge of antimicrobial resistance development as well as the general burden of infectious diseases. Its proprietary platform consists of a technology for selecting and producing Binding Proteins without targeting growth or killing the bacteria directly.